Pharmacogenetics of Naltrexone for Stimulant Abuse

NCT03226223 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Substance Use Disorders
Methamphetamine Abuse

Interventions

DRUG: Intranasal Methamphetamine

Sponsor

New York State Psychiatric Institute